Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CN Bio logo — Generate human-specific efficacy and safety data with Physi...

CN Bio

Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.

Founded 2008 United Kingdom Cambridge, United Kingdom 59 employees Series B Total: $43.67M Biopharma, Biotechnology +2

General Information

Company Name CN Bio
Founded Year 2008
Location United Kingdom Cambridge, United Kingdom
Employees 59
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series B
Business Model B2B, D2C, SaaS
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with CN Bio. To contact CN Bio, visit cn-bio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CN Bio compare?

A PDF of CN Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CN Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CN Bio

CN Bio, founded in 2008 and headquartered in the United Kingdom, is a pioneering player in the Biopharma and Biotechnology sectors, specializing in cutting-edge organ-on-a-chip technology.

Their flagship offering, the PhysioMimix® microphysiological systems, is designed to enhance the precision and speed of preclinical drug discovery by replicating human physiological responses. This approach provides a more translatable alternative to conventional animal models, addressing the need for human-specific data critical for advancing new therapeutics.

In April 2024, CN Bio received a substantial $21.00M Series B investment, led by prominent investors CN Innovations and Bayland Capital. With strong market demand and backing, the company is strategically positioned to redefine the drug development landscape, providing valuable tools for more reliable and efficient drug testing.

Business keywords: Organ-on-a-Chip, Microphysiological Systems, Preclinical Drug Discovery, Safety Toxicology, 3D Cell Culture, Primary Human Cells, Human-Specific Efficacy Data, Disease Modeling, Drug-Induced Liver Injury, Pharmaceutical and Biotech Research, Non-Alcoholic Steatohepatitis, Hepatitis B Disease Model, Precision Biology, Microfluidic Cell Culture, Viral Lifecycle Models

Services & Products

Organ-on-a-chip models
Non-Alcoholic Steatohepatitis studies
Drug-Induced Liver Injury studies
Custom study design for research goals
Multi-chip plates and consumables
Contract research services

Target Customers

Pharmaceutical companies Biotechnology researchers Laboratories focusing on drug efficacy Safety and ADME departments in healthcare

Pricing

as listed on Sep 29, 2026

On request

CN Bio's pricing page

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $21.00M 2
CN Innovations, Bayland Capital
23 Apr 2024
Series B $12.00M 1
GrayBella Capital
GrayBella Capital
01 Jul 2021
Grant Undisclosed 1
Innovate UK
Innovate UK
01 Mar 2021
Venture Round $9.00M 2
CITIC Securities
CITIC Securities, CN Innovations
02 Mar 2020
Grant £670.00K 1
Innovate UK
Innovate UK
11 Oct 2017
Seed Round £1.00M 1
CN Innovations
15 Jul 2009

CN Bio Alternatives & Competitors

View All Alternatives
CN Bio vs
MIMETAS
MIMETAS The Netherlands

Human Tissue Models for Better Therapies

Grant
93 employees
Biotechnology, Health Care
Compare CN Bio vs MIMETAS
CN Bio vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
Compare CN Bio vs Emulate, Inc.
CN Bio vs
Newcells Biotech (Axol Bioscience)
Newcells Biotech (Axol Bioscience) United Kingdom

The Newcells ophthalmology business was acquired by Axol Bioscience

12 employees
Biotechnology, Health Care
View all alternatives

FAQ About CN Bio

Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.
CN Bio was founded in 2008.
CN Bio is headquartered in Cambridge, United Kingdom.
CN Bio operates in Biopharma, Biotechnology, Health Care and Medical Devices. Its work centres on Organ-on-a-Chip, Microphysiological Systems, Preclinical Drug Discovery and Safety Toxicology. Its customers include Pharmaceutical companies, Biotechnology researchers and Laboratories focusing on drug efficacy.
CN Bio has a B2B, D2C and SaaS business model. Its revenue comes from Product Sales, Service Fee and Licensing.
As listed on CN Bio's pricing page on Sep 29, 2026: On request.
CN Bio has approximately 59 employees.
CN Bio has completed 6 funding rounds, raising a total of $43.67M. The latest funding stage is Series B.
CN Bio offers: Organ-on-a-chip models, Non-Alcoholic Steatohepatitis studies, Drug-Induced Liver Injury studies, Custom study design for research goals, Multi-chip plates and consumables, Contract research services.
Top alternatives and competitors to CN Bio include MIMETAS, Emulate, Inc., Newcells Biotech (Axol Bioscience), River BioMedics, NeuCyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CN Bio and MIMETAS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CN Bio, https://bouncewatch.com/company/cn-bio, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes